1. All veterans in the Department of Veterans Affairs healthcare system are eligible to receive new antiviral treatments – even those who did not contract the infection during military service. Veterans are also eligible regardless of the stage of the illness.
2. This comprehensive eligibility is a change from last year, when the department began restricting treatment to those with advanced liver disease.
3. Eligibility had been restricted due to an unexpectedly high demand for hepatitis C medication, however, this year Congress committed more funds to hepatitis C treatment for veterans. This year, Congress allocated $1.5 billion to the Department of Veterans Affairs, specifically for hepatitis C.
4. The department also aims to screen all veterans born between 1945 and 1965 for the infection, since this timeframe accounts for more than 75 percent of hepatitis C infections.
5. Hepatitis C is a leading cause of death in the United States, taking more lives than infections like HIV, tuberculosis and other conditions combined. This information is particularly concerning for veterans, since Vietnam veterans suffer from hepatitis C at a rate up to five times greater than the general population.
More articles on gastroenterology and endoscopy:
Biotechnology company Protagonist Therapeutics raises $90M: 4 things to know
El Paso geriatric/gastroenterology department receives 100 % patient satisfaction: 3 points
Madrigal Pharmaceuticals names Dr. Richard Levy to board: 4 points
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
